Literature DB >> 9661838

Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus among patients infected with human immunodeficiency virus: evidence of GBV-C/HGV sexual transmission.

A Ibáñez1, M Giménez-Barcons, A Tajahuerce, C Tural, G Sirera, B Clotet, J M Sánchez-Tapias, J Rodés, M A Martínez, J C Saiz.   

Abstract

The development of new antiretroviral agents may improve survival of HIV-infected individuals, and therefore chronic viral hepatitis may become more relevant in these patients. The presence of GBV-C/HGV and hepatitis C virus (HCV) RNA were investigated by reverse transcriptase-nested polymerase chain reaction in plasma from 168 Spanish HIV-infected patients belonging to four different risk groups: intravenous drug users (IVDUs), hemophiliacs, homosexuals, and heterosexuals. GBV-C/HGV-RNA and HCV-RNA were detected in 18% and 43% of the patients, respectively. The prevalence of current infection with these viruses was notably high, 19% for GBV-C/HGV and 69% for HCV, among individuals with parenteral risk of infection (intravenous drug abusers and hemophiliacs), but sexual transmission with GBV-C/HGV was also suggested because 16.5% of patients with sexual risk, either homosexual or heterosexual, had GBV-C/HGV-RNA in plasma. Although investigation of GBV-C/HGV-RNA possibly underestimates the actual prevalence of infection with GBV-C/HGV, the above data suggest that sexual contact may play a relevant role in the spread of this virus. Phylogenetic analysis showed no evidence for clustering of NS3 sequences into different genotypes or subtypes of GBV-C/HGV.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661838     DOI: 10.1002/(sici)1096-9071(199808)55:4<293::aid-jmv7>3.0.co;2-w

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

Review 1.  GB virus C/hepatitis G virus (GBV-C/HGV): still looking for a disease.

Authors:  M Sathar; P Soni; D York
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

2.  Investigation of saliva, faeces, urine or semen samples for the presence of GBV-C RNA.

Authors:  Q R Eugenia; Q R Ana; M Carmen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Age-dependent acquisition of hepatitis G virus/GB virus C in a nonrisk population: detection of the virus by antibodies.

Authors:  H H Feucht; M Schröter; B Zöllner; S Polywka; R Laufs
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Molecular evidence of mother-to-infant transmission of hepatitis G virus among women without known risk factors for parenteral infections.

Authors:  C Menéndez; J M Sánchez-Tapias; P L Alonso; M Giménez-Barcons; E Kahigwa; J J Aponte; H Mshinda; M M Navia; M T Jiménez de Anta; J Rodés; J C Saiz
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

5.  Prevalence of GB virus type C viraemia in MSM with or without HIV-1 infection in Beijing, China.

Authors:  Z Liu; L Li; Z Chen; M Xu; T Zhang; Y Jiao; B Sheng; D Chen; H Wu
Journal:  Epidemiol Infect       Date:  2012-03-26       Impact factor: 4.434

6.  IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients.

Authors:  Ester Aparicio; Mariona Parera; Sandra Franco; Nuria Pérez-Alvarez; Cristina Tural; Bonaventura Clotet; Miguel Angel Martínez
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

7.  The Effect of GBV-C Infection on CD4 Count and Viral Loads in Patients Infected With HIV.

Authors:  Hossein Keyvani; Avid Mohammadi; Masoud Sabouri Ghannad; Mahboobeh Hajabdolbaghi
Journal:  Hepat Mon       Date:  2012-01-20       Impact factor: 0.660

Review 8.  Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication.

Authors:  Yaqi Yu; Zhenzhou Wan; Jian-Hua Wang; Xianguang Yang; Chiyu Zhang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.